Trump's Executive Orders on Drug Pricing

This week, we bring you a very special episode of the podcast. I was a guest on The Political Pharmacist Podcast with host Eric Geyer to discuss President Trump's new executive orders on drug pricing. If you haven't listened to last week's episode on cashflow in pharmacy, I recommend you do that first as it will give you a good primer on PBMs, which will be impacted by these new laws.

Check out The Political Pharmacist Podcast for more!! Thank you Eric for having me as a guest!

President Trump just unveiled four new executive orders he plans to sign that can effect how Americans afford their prescription medications. These orders mainly affect how middlemen price savings are passed along to patients at the pharmacy counter with a few other more nuanced changes while also calling out the ridiculously high insulin and epinephrine (EpiPen) prices.

On this episode, I sit down with Dr. Benjamin Jolley and Dr. Katie Trotta to discuss the impact each of these may have on patients and pharmacies in the US, as well as if these are legal or are just political maneuvering by a president who is down in the polls.

Reference links to the podcast that you may find useful: Trump's Executive Order on PBMs: https://www.whitehouse.gov/presidential-actions/executive-order-lowering-prices-patients-eliminating-kickbacks-middlemen/

Dr. Jolley's blog: benjaminjolley.substack.com/archive

Bottle of Lies book: www.barnesandnoble.com/w/bottle-of-l…an/1129745540

Dangers of buying drugs online: nabp.pharmacy/newsroom/news/soci…5XB2sSDkmoN8wHU7fc